NCT02700659 - The Cxbladder Monitoring Study | Biotech Hunter

Enrollment

803

Participants

Timeline

Start Date

February 4, 2013

Primary Completion Date

September 23, 2016

Study Completion Date

September 23, 2016

Conditions

Urothelial Carcinoma

Interventions

OTHER

Cxbladder

Cxbladder is a non invasive UC detection test measuring five messenger RNA (mRNA) biomarkers present at elevated levels in patients presenting with urothelial carcinoma.

Trial Locations (11)

10065

Weill Cornell Medical College, Department of Urology, New York

12061

Premier Medical Group of the Hudson Valley, New York

12401

Premier Medical Group of the Hudson Valley, Kingston

12550

Premier Medical Group of the Hudson Valley, Newburgh

17033

Penn State Hershey Medical Center and College of Medicine, Hershey

32803

Florida Urology Associates, Orlando

35209

Urology Centers of Alabama, Homewood

75390

UT Southwestern Medical Center, Dallas

83642

Idaho Urologic Institute, Meridian

06052

Urology Center of Grove Hill, One Lake Street, New Britain

08054

Delaware Valley Urology, LLC, New Jersey